Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
45.76
+0.89 (+1.98%)
Official Closing Price
Updated: 4:10 PM EDT, May 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
30,501,524
Open
46.31
Bid (Size)
45.62 (100)
Ask (Size)
45.74 (300)
Prev. Close
44.87
Today's Range
45.53 - 47.55
52wk Range
35.12 - 81.44
Shares Outstanding
N/A
Dividend Yield
5.57%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Record Highs, Punished Results, and One Very Consequential Apple Rumor
↗
Today 3:38 EDT
Via
Chartmill
3 Absurdly Cheap Growth Stocks to Buy in May 2026
↗
May 04, 2026
These stocks have been struggling over the past year, but their growth days are far from over.
Via
The Motley Fool
Performance
YTD
-12.7%
-12.7%
1 Month
+24.8%
+24.8%
3 Month
-9.0%
-9.0%
6 Month
-5.2%
-5.2%
1 Year
-33.8%
-33.8%
More News
Read More
Here's Exactly Why Wall Street Thinks Viking Therapeutics Stock Could Soar 207% Over the Next 12 Months
↗
May 04, 2026
Via
The Motley Fool
Eli Lilly Just Announced Fantastic News for Shareholders
↗
May 04, 2026
Via
The Motley Fool
Topics
Earnings
Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026)
↗
May 02, 2026
Via
The Motley Fool
Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It Permanent
↗
May 01, 2026
Via
MarketBeat
Viking Therapeutics Faces Timeline Risk—But Upside Could Be Huge
↗
May 01, 2026
Via
MarketBeat
What's the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.
↗
April 30, 2026
Via
The Motley Fool
Is Eli Lilly Stock Undervalued at $870? 1 Top Wall Street Analyst Thinks So
↗
April 28, 2026
Via
The Motley Fool
Amazon Takes a Bite Out of Hims: What Its GLP-1 Entrance Means
↗
April 28, 2026
Via
MarketBeat
Is This Deal a Game Changer for Novo Nordisk?
↗
April 27, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Forget Weight Loss Drugs: Here's An Even Better Reason to Invest in Eli Lilly
↗
April 27, 2026
Via
The Motley Fool
This Obesity Stock Could More Than Double Over the Next 12 Months, According to Wall Street
↗
April 26, 2026
Via
The Motley Fool
Is This Tech Giant the Next Potential Winner in the GLP-1 Weight Loss Boom?
↗
April 25, 2026
Via
The Motley Fool
Why Eli Lilly Stock Flopped on Friday
↗
April 24, 2026
Via
The Motley Fool
Here's Why Agios Pharmaceuticals Stock Slumped This Week (And What Investors Have to Look Forward to in 2026)
↗
April 24, 2026
Via
The Motley Fool
Is Novo Nordisk's 72% Crash a Generational Buying Opportunity or a Value Trap?
↗
April 23, 2026
Via
The Motley Fool
The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial
April 23, 2026
From
Equity Insider
Via
GlobeNewswire
Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins
↗
April 23, 2026
Via
The Motley Fool
Stock Market Today, April 21: Hims & Hers Health Drops as Amazon Unveils Competing Weight Loss Program
↗
April 21, 2026
Via
The Motley Fool
Topics
Stocks
A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 Duopoly
↗
April 21, 2026
Via
The Motley Fool
Here's Why Agios Pharmaceuticals Crashed 23% Today
↗
April 20, 2026
Via
The Motley Fool
This Drug Stock Has Crushed the S&P 500 Over the Last Decade
↗
April 18, 2026
Via
The Motley Fool
Topics
Intellectual Property
Stocks
3 Ways to Invest in the Growing GLP-1 Weight Loss Market
↗
April 17, 2026
Via
MarketBeat
Is Viking Therapeutics the Ultimate Millionaire-Maker Obesity Stock for 2026?
↗
April 17, 2026
Via
The Motley Fool
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 45.76
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 05/06/26 04:10 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.